qESPCR demonstrated that TET2 exon 2 is expressed at significantly lower levels in AML samples compared to normal bone marrow cells, which occurred in the absence of notable changes in the expression of the full TET2 gene. This evidence concerns the gene TET2 and acute myeloid leukemia.